Under construction – not a live service

Skip to content

Frontlight Research

Trial site

Arlington Dermatology /ID# 263001

Rolling Meadows, Illinois 60008, United StatesNot linked to an institution yet

1closed trial

The trials here

What the trial at this site is about, from its registry record.

Conditions: Psoriasis

Closed trials

Completed
A Study to Learn How Safe and Effective Risankizumab is When Compared to Deucravacitinib to Treat Participants With Moderate Plaque Psoriasis and Who Need to Try Systemic Treatment (Works Throughout the Whole Body)
NCT06333860· Phase 4· AbbVie· Source

Site data: ClinicalTrials.govUpdated 12 Nov 2026

Report an error

Under construction, not live – Arlington Dermatology /ID# 263001: trial site – Frontlight Research